VALVE COMPLICATIONS AND MANAGEMENT | SESSION ONE

Saturday, March 8, 2025

2:00 PM – 3:43 PM ET

Moderator(s)

Itsik Ben-Dor, MD

WHC
MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose
Christian Shults, MD

Cardiac Surgeon
MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Isaac George, MD

Associate Professor of Surgery (in Medicine)
New York Presbyterian - Columbia University Medical Center
New York, New York, United States

Disclosure(s): Atricure: Consultant (Ongoing); Boston Scietific: Consultant (Ongoing); CardioMech: Consultant (Ongoing); DurVena Inc: Consultant (Ongoing); Edward Lifesciences: Consultant (Ongoing); medtronic.: Consultant (Ongoing); Valcare Medical: Consultant (Ongoing); VDyne: Consultant (Ongoing)
Rony Lahoud, MD

Associate Professor
University of Vermont
S. Burlington, Vermont, United States

Disclosure(s): medtronic.: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Michael R. Mooney, MD, FACC, FAHA, FSCAI

Director, Coronary Therapeutics
Minneapolis Heart Institute at Abbott Northwestern Hospital
Minneapolis, Minnesota, United States

Disclosure(s): No financial relationships to disclose
Mehul Patel, MD

Director of SHD
Methodist LeBonheur Healthcare
Germantown, Tennessee, United States

Disclosure(s): Edwards Lifesciences LLC: Proctor (Ongoing); Medtronic Inc: Proctor (Ongoing)
Michael Ragosta, MD

Director, Cardiac Catheterization Laboratory
University of Virginia
Charlottesville, Virginia, United States

Disclosure(s): No financial relationships to disclose
David A. Wood, MD FRCPC FACC FESC

Head, VCH Division of Cardiology; Director, UBC Centre for Cardiovascular Innovation
UBC Centre For Cardiovascular Innovation
Vancouver, British Columbia, Canada

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Excision Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Steven J. Yakubov, MD, FACC, MSCAI

System/Medical Chief - Structural Heart Disease
OhioHealth/Riverside Methodist Hospital
Columbus, Ohio, United States

Disclosure(s): BioStar: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Foldax: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Itsik Ben-Dor, MD: No financial relationships to disclose

Samir R. Kapadia, MD, FSCAI: No financial relationships to disclose

Christian Shults, MD: No financial relationships to disclose

Isaac George, MD: Atricure: Consultant (Ongoing); Boston Scietific: Consultant (Ongoing); CardioMech: Consultant (Ongoing); DurVena Inc: Consultant (Ongoing); Edward Lifesciences: Consultant (Ongoing); medtronic.: Consultant (Ongoing); Valcare Medical: Consultant (Ongoing); VDyne: Consultant (Ongoing)

Rony Lahoud, MD: medtronic.: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Michael R. Mooney, MD, FACC, FAHA, FSCAI: No financial relationships to disclose

Mehul Patel, MD: Edwards Lifesciences LLC: Proctor (Ongoing); Medtronic Inc: Proctor (Ongoing)

Michael Ragosta, MD: No financial relationships to disclose

David A. Wood, MD FRCPC FACC FESC: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Excision Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Steven J. Yakubov, MD, FACC, MSCAI: BioStar: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Foldax: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing)